• Media type: E-Article
  • Title: Genetic Variants Influencing Circulating Lipid Levels and Risk of Coronary Artery Disease
  • Contributor: Waterworth, Dawn M.; Ricketts, Sally L.; Song, Kijoung; Chen, Li; Zhao, Jing Hua; Ripatti, Samuli; Aulchenko, Yurii S.; Zhang, Weihua; Yuan, Xin; Lim, Noha; Luan, Jian'an; Ashford, Sofie; Wheeler, Eleanor; Young, Elizabeth H.; Hadley, David; Thompson, John R.; Braund, Peter S.; Johnson, Toby; Struchalin, Maksim; Surakka, Ida; Luben, Robert; Khaw, Kay-Tee; Rodwell, Sheila A.; Loos, Ruth J.F.; [...]
  • imprint: Ovid Technologies (Wolters Kluwer Health), 2010
  • Published in: Arteriosclerosis, Thrombosis, and Vascular Biology
  • Language: English
  • DOI: 10.1161/atvbaha.109.201020
  • ISSN: 1079-5642; 1524-4636
  • Keywords: Cardiology and Cardiovascular Medicine
  • Origination:
  • Footnote:
  • Description: <jats:p> <jats:bold> <jats:italic>Objective—</jats:italic> </jats:bold> Genetic studies might provide new insights into the biological mechanisms underlying lipid metabolism and risk of CAD. We therefore conducted a genome-wide association study to identify novel genetic determinants of low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides. </jats:p> <jats:p> <jats:bold> <jats:italic>Methods and Results—</jats:italic> </jats:bold> We combined genome-wide association data from 8 studies, comprising up to 17 723 participants with information on circulating lipid concentrations. We did independent replication studies in up to 37 774 participants from 8 populations and also in a population of Indian Asian descent. We also assessed the association between single-nucleotide polymorphisms (SNPs) at lipid loci and risk of CAD in up to 9 633 cases and 38 684 controls. We identified 4 novel genetic loci that showed reproducible associations with lipids (probability values, 1.6×10 <jats:sup>−8</jats:sup> to 3.1×10 <jats:sup>−10</jats:sup> ). These include a potentially functional SNP in the <jats:italic>SLC39A8</jats:italic> gene for HDL-C, an SNP near the <jats:italic>MYLIP/GMPR</jats:italic> and <jats:italic>PPP1R3B</jats:italic> genes for LDL-C, and at the <jats:italic>AFF1</jats:italic> gene for triglycerides. SNPs showing strong statistical association with 1 or more lipid traits at the <jats:italic>CELSR2</jats:italic> , <jats:italic>APOB</jats:italic> , <jats:italic>APOE-C1-C4-C2</jats:italic> cluster, <jats:italic>LPL</jats:italic> , <jats:italic>ZNF259-APOA5-A4-C3-A1</jats:italic> cluster and <jats:italic>TRIB1</jats:italic> loci were also associated with CAD risk (probability values, 1.1×10 <jats:sup>−3</jats:sup> to 1.2×10 <jats:sup>−9</jats:sup> ). </jats:p> <jats:p> <jats:bold> <jats:italic>Conclusion—</jats:italic> </jats:bold> We have identified 4 novel loci associated with circulating lipids. We also show that in addition to those that are largely associated with LDL-C, genetic loci mainly associated with circulating triglycerides and HDL-C are also associated with risk of CAD. These findings potentially provide new insights into the biological mechanisms underlying lipid metabolism and CAD risk. </jats:p>